Selected article for: "aberrant robust and acute respiratory syndrome"

Author: Jason W. Westerbeck; Carolyn E. Machamer
Title: The Infectious Bronchitis Virus Coronavirus Envelope Protein Alters Golgi pH to Protect Spike Protein and Promote Release of Infectious Virus
  • Document date: 2018_10_11
  • ID: amg5dice_1
    Snippet: The majority of human coronaviruses (CoVs) cause mild disease phenotypes. However, when novel coronaviruses like severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV emerge from their animal reservoirs to infect humans they elicit a robust and aberrant immune response that can lead to a very serious and deadly pneumonia (1) (2) (3) . Importantly, there are no effective vaccines or therapeutics to treat thes.....
    Document: The majority of human coronaviruses (CoVs) cause mild disease phenotypes. However, when novel coronaviruses like severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV emerge from their animal reservoirs to infect humans they elicit a robust and aberrant immune response that can lead to a very serious and deadly pneumonia (1) (2) (3) . Importantly, there are no effective vaccines or therapeutics to treat these CoVs. Efforts to develop long-term therapeutic strategies to combat novel, highly pathogenic CoVs will be aided by increased understanding of conserved viral mechanisms at the level of their cell and molecular biology.

    Search related documents:
    Co phrase search for related documents